Today: 7 February 2026
Subscribe
Browse Category

NYSE:IBM News 28 July 2025 - 29 July 2025

AI Won’t Steal Your Job – It Will Supercharge Your Career in 2025 🚀

AI Won’t Steal Your Job – It Will Supercharge Your Career in 2025 🚀

The World Economic Forum’s Future of Jobs Report 2025 projects that 44% of worker skills will change by 2027 due to AI and related trends. In 2025 more than 80,000 job ads mentioned generative AI expertise, up from 3,700 in 2010. AI-related job listings grew roughly 29% annually over the past 15 years, with over 50% of AI-skilled postings in non-tech fields in 2024. AI skills are associated with about 28% higher salaries on average versus similar roles without AI requirements. Candidates optimizing resumes with AI-driven keyword suggestions report landing 3× as many interviews. GitHub Copilot helps developers complete tasks
29 July 2025
····
The AI Revolution Has Only Just Begun – How Artificial Intelligence Is Transforming Everything

The AI Revolution Has Only Just Begun – How Artificial Intelligence Is Transforming Everything

In 1997, IBM’s Deep Blue defeated world chess champion Garry Kasparov. In 2011, IBM’s Watson beat Jeopardy! champions Ken Jennings and Brad Rutter. In 2012, a deep learning system developed by Geoffrey Hinton and colleagues won an image-recognition contest by a large margin, kicking off the deep learning revolution. In 2014, Google acquired DeepMind. In 2016, Google DeepMind’s AlphaGo defeated world Go champion Lee Sedol. In 2015, OpenAI was founded by Sam Altman, Elon Musk, Ilya Sutskever and others. In late 2022, OpenAI’s ChatGPT launched publicly and reached 100 million users within two months. By 2023, Midjourney had over 15
28 July 2025
·····
1 … 5 6 7

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
New York, Feb 7, 2026, 09:35 EST — Market closed. Roivant Sciences Ltd shares leapt on Friday after the company reported positive mid-stage results for its immune-modulating drug brepocitinib in a rare skin disease, and paired the readout with its quarterly financial update. The Nasdaq-listed stock closed up 22.4% at $25.82, leaving traders to gauge whether the move has legs when U.S. markets reopen on Monday, Feb. 9. It matters because Roivant is trying to turn a late-stage pipeline into approvals, and the market has been quick to reward biotechs that can show clean efficacy in controlled trials. The company
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
Go toTop